Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus-Reference-Cited by-同舟云学术

Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus

Published:2022-11 Issue:5-6 Volume:60 Page:106682
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Huang Yu-Shan,Sun Hsin-Yun^ORCID,Chang Sui-Yuan,Chuang Yu-Chung,Su Yi-Ching,Liu Wen-Chun,Hung Chien-Ching^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference34 articles.

1. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS);Thio;Lancet,2002

2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV,2020

3. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy;Matthews;AIDS,2006

4. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients;Benhamou;Hepatology,1999

5. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review;Sun;World J Gastroenterol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study;Viruses;2023-08-12

2. Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients;Microbiology Spectrum;2023-06-15